Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Trading Statement

14 Jun 2012 07:00

RNS Number : 3337F
Computacenter PLC
14 June 2012
 

Computacenter plcTrading Update14 June 2012

'Significant new business wins to incur additional start-up costs in 2012'

Computacenter plc, Europe's leading independent provider of IT infrastructure services, today publishes a trading update and outlook for the full year, based on unaudited information.As we stated at the time of our Interim Management Statement on 18 April 2012, Services revenue growth has increased substantially and is likely to have grown in excess of 15% at a Group level, in constant currency, during the first half of 2012. This is clearly an acceleration, compared to the 11% growth rate experienced in the first quarter. As we look forward into the rest of the year, we see no indications that this growth rate will moderate, as it is underpinned by contracts already won, as well as a substantial new business pipeline.We expect that our Supply Chain business will experience high single digit growth for H1 2012 and while there are sectors of challenging market conditions, such as investment banking in the UK and the public sector in France, caused by the uncertainty around the changes in their Government, investment by our customers in capital expenditure projects, remains satisfactory.We are clearly pleased with the substantial Services growth rate, which is testament to the commercial market's appetite for Computacenter's offerings and our track record of excellent execution for our clients. However, it has become apparent to the Board that the significant amount of new business growth requires material investment through our P&L, to deliver successful take-on of the new business and drive high customer satisfaction to underpin Computacenter's success in the years ahead.The take-on cost of this new business includes, but is not limited to, the recruitment of over 700 new Services personnel and the transfer of many staff from customers and their historical suppliers. Clearly, there are material recruitment and training costs for these new starters. Our investment in systems, both back office and customer facing, has also been substantial. Understandably, we are seeing these capital investments increase our depreciation costs. The new business has also attracted significant costs associated to sales commissions, which are predominately paid up-front.These incremental investments to support our future growth are likely to cost Computacenter in the region of an additional £7 million in 2012, compared with our previous expectations. It should also be noted that the depreciation of the euro against sterling, if it were to remain at the current level, would impact Computacenter's profit in 2012 by approximately an additional £3 million.

Mike Norris, CEO of Computacenter said: 'While we highlighted the necessity for investment in our statement of 18 April 2012, both the size and scope of the opportunities we have won have increased significantly, requiring us to invest further.'

Our next scheduled trading update will be the pre-close update prior to our Interim Results, which is scheduled for 17 July 2012.Enquiries:

Computacenter plc:Mike Norris, Chief Executive 01707 631601Tony Conophy, Finance Director 01707 631515Tessa Freeman, PR Manager 01707 631514Tulchan Communications: 020 7353 4200

Christian CowleyRebecca Scott

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFJMLTMBBBBPT
Date   Source Headline
1st Aug 20246:03 pmRNSTransaction in Own Shares
1st Aug 202412:00 pmRNSTotal Voting Rights
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
31st Jul 20246:21 pmRNSTransaction in Own Shares
30th Jul 20246:22 pmRNSTransaction in Own Shares
30th Jul 202410:15 amRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:10 amRNSShare Buyback Programme – 26 July 2024
26th Jul 20247:00 amRNSTrading Update and Return of Value – 26 July 2024
2nd Jul 202410:00 amRNSDirectorate Change -Confirmation of Effective Date
5th Jun 20247:00 amRNSCapital Markets Day
14th May 20242:00 pmRNSResult of AGM
1st May 20247:00 amRNSQ1 Trading Update
11th Apr 20241:00 pmRNS2023 Annual Financial Report & Notice of 2024 AGM
5th Apr 20247:00 amRNSDirectorate Change - Holding Announcement
4th Apr 20243:00 pmRNSDirector/PDMR Shareholding
27th Mar 20241:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSChange of Chair
20th Mar 20247:00 amRNSFinal Results 2023
5th Feb 20241:00 pmRNSBlock listing Interim Review
24th Jan 20247:00 amRNSPre-Close Trading Statement
30th Oct 202311:00 amRNSQ3 2023 Trading Update Replacement
30th Oct 20237:05 amRNSAppointment of Corporate Broker
30th Oct 20237:00 amRNSQ3 2023 Trading Update
17th Oct 20231:00 pmRNSDirector/PDMR Shareholding
12th Sep 202311:00 amRNSDirector/PDMR Shareholding
8th Sep 20237:00 amRNSHalf-year Report
8th Aug 202311:30 amRNSBlock listing Interim Review
14th Jun 202312:00 pmRNSHolding(s) in Company
7th Jun 202312:00 pmRNSDirector/PDMR Shareholding
6th Jun 20234:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSQ1 2023 Trading Update
17th Apr 20231:31 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20233:15 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSDirector/PDMR Shareholding
31st Mar 20231:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSFinal Results 2022
28th Mar 20237:00 amRNSFY2022 results release date - UPDATE
14th Mar 20237:00 amRNSFY2022 results revised date; guidance unchanged
2nd Mar 202310:00 amRNSHolding(s) in Company
17th Feb 202310:00 amRNSHolding(s) in Company
9th Feb 20239:30 amRNSHolding(s) in Company
6th Feb 202311:15 amRNSBlock listing Interim Review
30th Jan 20237:00 amRNSPre-Close Trading Statement
9th Dec 202212:30 pmRNSDirectorate Change - Update
9th Dec 202212:00 pmRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.